Skip to main content
. 2021 Jan 25;92(1):e2021070. doi: 10.23750/abm.v92i1.10847

Table 2.

Seroprevalence in recruited subjects stratified by gender, age-group, symptoms, and risk factors.

Tot Positive (%) a p-value
Total subjects 341 49 (14.4)
Male
Female		 165
176		 25 (15.2)
24 (13.6)		 0.690 b
Age groups
20-29
30-39
40-49
50-59
60-69
>70		 38
59
92
87
43
10		 4 (10.5)
8 (13.6)
10 (10.9)
14 (16.1)
9 (20.9)
3 (30.0)		 0.403 b
Risk contacts 11 8 (72.7) 0.192 (0.000) c
Symptoms
Yes/no
Fever
Cough
Cold/Sore throat
Conjunctivitis
Loss taste/smell
Respiratory difficulties		 25
16
15
13
3
7
5		 9 (36.0)
6 (37.5)
6 (40.0)
1 (7.7)
0 (0.0)
4 (57.1)
2 (40.0)		 0.173 (0.001) c
0.146 (0.007) c
0.157 (0.004) c
ns c
ns c
0.177 (0.001) c
ns c
Risk factors
Smoking habit
Cardiovascular diseases
Diabetes
Respiratory diseases
Digestive tract diseases		 88
32
7
11
7		 7 (8.0)
9 (28.1)
1 (14.3)
2 (18.2)
0 (0.0)		 - 0.108 (0.047)c
0.126 (0.020)c
ns c
ns c
ns c

aIgM and/or IgG positivity

bChi-squared test

cSpearman’s test